BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15967786)

  • 21. [B cell activated co-receptor].
    Ruan X; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):436-9. PubMed ID: 12905672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subsets of CD4 T cells and B cell activation.
    Bottomly K
    Semin Immunol; 1989 Sep; 1(1):21-31. PubMed ID: 15630956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19.
    Sato S; Steeber DA; Jansen PJ; Tedder TF
    J Immunol; 1997 May; 158(10):4662-9. PubMed ID: 9144478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
    J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication of established B-cell lymphoma by CD19-specific murine T cells is dependent on host lymphopenic environment and can be mediated by CD4+ and CD8+ T cells.
    Cheadle EJ; Hawkins RE; Batha H; Rothwell DG; Ashton G; Gilham DE
    J Immunother; 2009 Apr; 32(3):207-18. PubMed ID: 19242379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Floating the raft hypothesis: the roles of lipid rafts in B cell antigen receptor function.
    Cheng PC; Cherukuri A; Dykstra M; Malapati S; Sproul T; Chen MR; Pierce SK
    Semin Immunol; 2001 Apr; 13(2):107-14. PubMed ID: 11308294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.
    Vlková M; Thon V; Sárfyová M; Bláha L; Svobodník A; Lokaj J; Litzman J
    Clin Exp Immunol; 2006 Feb; 143(2):373-9. PubMed ID: 16412063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the early molecular events underlying B cell activation.
    Harwood NE; Batista FD
    Immunity; 2008 May; 28(5):609-19. PubMed ID: 18482567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.
    Fearon DT; Carroll MC
    Annu Rev Immunol; 2000; 18():393-422. PubMed ID: 10837064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
    Smith AJ; Gordon TP; Macardle PJ
    Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cell receptor-mediated internalization of salmonella: a novel pathway for autonomous B cell activation and antibody production.
    Souwer Y; Griekspoor A; Jorritsma T; de Wit J; Janssen H; Neefjes J; van Ham SM
    J Immunol; 2009 Jun; 182(12):7473-81. PubMed ID: 19494270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
    Liu X; Zhang L; Zhang X; Yu H; Zhao X; Lu J; Qian G; Ge S
    Int J Oncol; 2007 Jun; 30(6):1389-96. PubMed ID: 17487359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
    Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
    Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-cell activation in patients with irritable bowel syndrome (IBS).
    Ohman L; Lindmark AC; Isaksson S; Posserud I; Strid H; Sjövall H; Simrén M
    Neurogastroenterol Motil; 2009 Jun; 21(6):644-50, e27. PubMed ID: 19222763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens.
    Cherukuri A; Cheng PC; Pierce SK
    J Immunol; 2001 Jul; 167(1):163-72. PubMed ID: 11418645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation.
    Mejri N; Gottstein B
    Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
    Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The CD19 molecule is crucial for MID-dependent activation of tonsillar B cells from children.
    Hadzic R; Forsgren A; Cardell LO; Riesbeck K; Wingren AG
    Scand J Immunol; 2005 Feb; 61(2):165-72. PubMed ID: 15683453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.